The Merck Group, which is headquartered in Darmstadt, Germany, is a global corporate group. With a history dating back nearly 350 years, it is the world’s oldest pharmaceutical and chemical company. Merck holds the global rights to the Merck name and brand. The only exceptions are Canada and the United States, where Merck operates as EMD. Merck’s product portfolio ranges from innovative pharmaceuticals and biopharmaceutical products, to specialty chemicals, high-tech materials and life science tools. Merck markets its wide range of products within its four divisions: Merck Serono, Consumer Health, Performance Materials and Merck Millipore. Merck Group | Sales [...]
Overview – Q1 2014 Solid organic sales growth of around 4% outweighed by currency headwinds All divisions contribute to organic growth Profitability remains high – EBITDA pre one-time items up slightly to € 807 million despite substantial reduction in royalty, license and commission income as well as negative currency impact Earnings per share pre one-time items up 9.5% to € 2.31 Strong business free cash flow underscores financial strength High equity ratio as well as increased liquid funds reflect solid balance sheet structure XLS Merck Group | Key figures € million Q1 – 2014 Q1 – 2013 Change in % Total revenues 2,664.8 2,760.5 –3.5 Sales 2,613.9 [...]
XLS Merck Serono | Key figures € million Q1 – 2014 Q1 – 2013* Change in % * The previous year’s figures have been adjusted, see “The Merck Group and its divisions”. Total revenues 1,421.1 1,482.1 –4.1 Sales 1,374.9 1,388.8 –1.0 Operating result (EBIT) 235.8 170.2 38.5 Margin (% of sales) 17.2 12.3 EBITDA 428.0 408.3 4.8 Margin (% of sales) 31.1 29.4 EBITDA pre one-time items 438.0 437.7 0.1 Margin (% of sales) 31.9 31.5 Business free cash flow 480.0 340.0 41.2 Development of total revenues and sales as well as results of operations In the first quarter of 2014, total revenues of the Merck Serono division grew organically by 0.8%. However, owing to [...]
XLS Consumer Health | Key figures € million Q1 – 2014 Q1 – 2013* Change in % * The previous year’s figures have been adjusted, see “The Merck Group and its divisions”. Total revenues 180.5 181.8 –0.7 Sales 180.2 181.7 –0.8 Operating result (EBIT) 36.7 36.8 – Margin (% of sales) 20.4 20.2 EBITDA 39.1 39.4 –0.8 Margin (% of sales) 21.7 21.7 EBITDA pre one-time items 41.3 39.3 5.0 Margin (% of sales) 22.9 21.6 Business free cash flow 16.2 20.8 –22.5 Development of total revenues and sales as well as results of operations In the first quarter of 2014, the Consumer Health division generated sales of € 180 million (Q1 2013: € 182 million). The [...]
[...] organization and reporting structure of the Merck Group. The fields of activity of the individual divisions are described in detail in the sections about the divisions in the interim management report. The column “Corporate and Other” includes assets and liabilities as well as income and expenses that cannot be directly allocated to the reportable segments; it serves the reconciliation to the Group numbers. These mainly relate to Group functions. The cash flows from the financial result and income taxes are also disclosed under “Corporate and Other”. Apart from sales, the success of a segment is mainly determined by EBITDA pre one-time items (segment [...]
